{"mainPropery":{"diseaseId":5836,"diseaseName":"Aplastic anemia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5836/aplastic-anemia","synonyms":["Anemia aplastic","Aplastic anemia idiopathic","Idiopathic aplastic anemia","Secondary aplastic anemia"],"synonyms-with-source":[{"name":"Anemia aplastic"},{"name":"Aplastic anemia idiopathic"},{"name":"Idiopathic aplastic anemia"},{"name":"Secondary aplastic anemia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"609135"},{"identifierType":"ORPHANET","identifierId":"88"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":636,"resourceName":"Aplastic Anemia and MDS International Foundation","abbreviation":"","address1":"4330 East-West Highway, Suite 230","address2":"","address3":"","address4":"","address5":"","city":"Bethesda","state":"MD","zip":"20814 ","country":"United States","phone":"+1-301-279-7202 ","tty":"","tollFree":"1-800-747-2820 Option 2 (Helpline)","fax":"+1-301-279-7205 ","email":"help@aamds.org","url":"https://www.aamds.org","freeText":""},{"resourceID":2737,"resourceName":"Aplastic Anemia and Myelodysplasia Association of Canada","abbreviation":"AAMAC","address1":"11181 Yonge Street","address2":"Suite 321","address3":"","address4":"","address5":"","city":"Richmond Hill, ON","state":"","zip":"","country":"Canada","phone":" 905-780-0698","tty":"","tollFree":"1-888-840-0039","fax":" 905-780-1648","email":"info@aamac.ca","url":"http://www.aamac.ca/"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/609135' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Aplastic+anemia+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Aplastic anemia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Aplastic+anemia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Aplastic anemia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0002874' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000554.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/198759-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022929' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=88' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merck.com/mmpe/sec11/ch130/ch130f.html' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1558,"resourceId":2184,"resourceName":"National Heart, Lung, and Blood Institute","descriptionText":"The <a href='http://www.nhlbi.nih.gov/health/dci/Diseases/aplastic/aplastic_whatis.html' target='_blank'>National Heart, Lung, and Blood Institute</a> (NHLBI) has information on this topic. NHLBI is part of the National Institutes of Health and supports research, training, and education for the prevention and treatment of heart, lung, and blood diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:609135' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Aplastic anemia. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Aplastic anemia:<br />\r\n<a href='http://pedimds.org/patient/' target='_blank'>The Pediatric Myelodysplastic Syndrome (MDS) and Bone Marrow Failure (BMF) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":2781,"resourceId":4265,"resourceName":"Autoimmune Registry","descriptionText":"The <a href='http://www.autoimmuneregistry.org/' target='_blank'>Autoimmune Registry</a> supports research for Aplastic anemia by collecting information about patients with this and other autoimmune diseases. You can join the registry to share your information with researchers and receive updates about participating in new research studies.&nbsp;<a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries.</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2508,"questionText":"What is aplastic anemia?","answerText":"<strong>Aplastic anemia</strong>&nbsp;is a blood disorder caused by failure of the <a href=\"https://medlineplus.gov/bonemarrowdiseases.html\" target=\"_blank\">bone marrow</a> to make enough new blood cells. Bone marrow is a sponge-like tissue inside the bones that makes stem cells that develop into red blood cells, white blood cells, and platelets.[12677] Symptoms may include fatigue, weakness, dizziness, shortness of breath, frequent infections, and bleeding. Aplastic anemia can lead to other health concerns such as an irregular heartbeat, an enlarged heart, and heart failure. It can be caused by injury to blood stem cells due to exposure to certain drugs, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002324.htm\" target=\"_blank\">chemotherapy</a>, congenital disorders, drug therapy to suppress the immune system, pregnancy, radiation therapy, or toxins such as <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002720.htm\" target=\"_blank\">benzene</a> or arsenic. When the cause is unknown, it is referred to as idiopathic aplastic anemia. In about half of all cases, no cause can be found. The blood disorder can be <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002215.htm\" target=\"_blank\">acute</a> or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm\" target=\"_blank\">chronic</a>.[1591] Treatment may consist of&nbsp;supportive care only, <a href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/treatment\" target=\"_blank\">blood transfusions</a>, medicines to suppress the immune system, or <a href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/treatment\" target=\"_blank\">hematopoietic cell transplantation</a>.[9235]&nbsp;\r\n<div class=\"AdUnit\" id=\"ads-pos-1122\" style=\"display: none;\">\r\n<!--para, childcount:3-->        <br />\r\nThe British Committee for Standards in Haematology recommends treating infection or uncontrolled bleeding before administering immunosuppressive therapy, including in patients scheduled for HCT.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>5</a>] </sup>In the presence of severe infection, however, it may be necessary to proceed directly to HCT to provide the patient with the best chance for early neutrophil recovery.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>5</a>] </sup>&nbsp;The Pediatric Haemato-Oncology Italian Association recommends HCT from a matched sibling donor&nbsp;for severe aplastic anemia, and if a matched donor is not available, options include immunosuppressive therapy or unrelated donor HCT.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>6</a>] </sup><br />\r\n<!--para, childcount:1-->        <br />\r\nApproximately one third of patients with aplastic anemia do not respond to immunosuppression. The thrombopoietin-receptor agonist eltrombopag is approved for use in patients with severe aplastic anemia who fail to respond adequately to immunosuppressive therapy. Independent of response or degree of response, risks include&nbsp; relapse and late-onset clonal disease, such as paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic syndrome (MDS), or leukemia.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>14</a>, <a>38</a>, <a>39</a>, <a>40</a>, <a>41</a>] </sup><br />\r\n<div class=\"txtAd520SpcHolder\" id=\"plcHold-520\">\r\n<div class=\"AdUnit\" id=\"ads-pos-520\" style=\"display: none;\" data-google-query-id=\"CNuz7pfc8tQCFRM6TwodD0sOUA\">\r\n<div id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_1__container__\" style=\"border: 0pt currentcolor;\"><iframe name=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_1\" width=\"2\" height=\"3\" title=\"3rd party ad content\" id=\"google_ads_iframe_/4312434/profpromo/medscprefdesktop_1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" style=\"border: 0px; vertical-align: bottom;\"></iframe>\r\n<!--para, childcount:3-->        <br />\r\nPregnant women with aplastic anemia have a 33% risk of relapse.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>5</a>] </sup>Provide supportive care in these patients, maintain the platelet count above 20 &times; 10<sup>9</sup>/L, if possible, and consider administering cyclosporine.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>5</a>] </sup><br />\r\n<div class=\"AdUnit\" id=\"ads-pos-1520\" style=\"display: none;\">\r\n<!--para, childcount:1-->        <br />\r\nNote that monotherapy with hematopoietic growth factors (eg, recombinant human erythropoietin [rHuEPO], granulocyte colony-stimulating factor [G-CSF]) is not recommended for newly diagnosed patients.<sup>          <!--reference_ids_tool_tip reference_ids--> [<a>5</a>] </sup><br />\r\n<!--para, childcount:0-->        <br />\r\nFrequent outpatient follow-up for patients with aplastic anemia is needed to monitor blood counts and any adverse effects of various drugs. Transfusions of packed red blood cells (RBCs) and platelets are administered on an outpatient basis.</div>\r\n</div>\r\n</div>\r\n</div>\r\n</div>","dateModified":"2017-07-05T00:00:00"},"basicQuestions":[{"questionId":2509,"questionText":"What are the signs and symptoms of acquired aplastic anemia?","answerText":"The symptoms of aplastic anemia vary depending on how severe it is and how low blood counts are. Signs and symptoms may include:[1591][9235][12711]<br />\r\n<ul>\r\n    <li>Low numbers of red blood cells (anemia): May cause paleness (pallor), headache, palpitations,&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003077.htm\" target=\"_blank\" style=\"font-size: 12pt;\">rapid heart rate</a><span style=\"font-size: 12pt;\">,&nbsp;feeling out of breath, fatigue, or foot swelling.</span></li>\r\n    <li>Low numbers of platelets (thrombocytopenia): May result in gum bleeding, nosebleeds or bleeding in the internal organs and skin bruises.</li>\r\n    <li>Low white blood cells (neutropenia): May present infections, recurrent infections, mouth  sores.&nbsp;</li>\r\n</ul>","dateModified":"2017-07-05T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1591,"authors":"","articleTitle":"Aplastic Anemia","bookWebsiteJournalTitle":"MedlinePlus","date":"August 2016","volume":"","pages":"","url":"https://medlineplus.gov/aplasticanemia.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":9235,"authors":"Bakhshi S","articleTitle":"Aplastic Anemia Treatment & Management","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/198759-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12711,"authors":"","articleTitle":"Treatments","bookWebsiteJournalTitle":"The Aplastic Anemia and MDS International Foundation","date":"4/19/2016","volume":"","pages":"","url":"http://www.aamds.org/diseases/aplastic-anemia/treatment","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2511,"questionText":"How might aplastic anemia be treated?","answerText":"Treatment for aplastic anemia varies depending on the severity. While some individuals with mild to moderate aplastic anemia may not require treatment, for others, treatment may include:[9235][12710]<br />\r\n<ul>\r\n    <li><a href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/bt\" target=\"_blank\">Blood transfusions</a> to keep blood cell counts at acceptable levels</li>\r\n    <li><a href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/bmsct\" target=\"_blank\">Blood and marrow stem cell transplants</a> to replace damaged stem cells with health ones from a donor (another person)</li>\r\n    <li>Medications to stimulate the bone marrow, suppress the immune system, and prevent and treat infections</li>\r\n</ul>\r\nBlood and marrow stem cell transplants may cure aplastic anemia in some instances. This treatment option works best in children and young adults with severe aplastic anemia who are otherwise in good health.[12710]<br />\r\n<br />\r\nFor patients with severe aplastic anemia who are under the age of 20 years, and those ages 20 to 50 years who are otherwise in good health the first option is the transplant when a sibling donor is available.  For those who do not have an available sibling donor, the medication  eltrombopag or eltrombopag plus immunesuppression therapy can be used.<br />\r\n<br />\r\nFor patients over 50 years of age, the decision is based on the patient&rsquo;s overall health,  and preferences, and treatment may include eltrombopag or eltrombopag plus immunesuppression therapy (horse anti-thymocyte globulin (ATG), cyclosporin A (CSA), and glucocorticoids). People older than 50 years old have more risks of having rejection with the transplant and have greater risks of treatment toxicity and early mortality.","dateModified":"2017-07-05T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9235,"authors":"Bakhshi S","articleTitle":"Aplastic Anemia Treatment & Management","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/198759-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12710,"authors":"","articleTitle":"How Is Aplastic Anemia Treated?","bookWebsiteJournalTitle":"National Heart, Lung, and Blood Institute","date":"5/17/2012","volume":"","pages":"","url":"https://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/treatment","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2512,"questionText":"What is the long-term outlook for aplastic anemia?","answerText":"A small number of people with aplastic anemia may spontaneously recover with supportive care; however, for most individuals, the condition worsens without identification and treatment of the underlying cause and/or treatment of the disease. Bone marrow transplant may cure the disease in children and young patients and has a 10 year survival rate of approximately 73%. For many, bone marrow transplant is not an option due to the risks and potential long-term side effects.[9235][12711][12710]","dateModified":"2017-07-05T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":9235,"authors":"Bakhshi S","articleTitle":"Aplastic Anemia Treatment & Management","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/198759-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12710,"authors":"","articleTitle":"How Is Aplastic Anemia Treated?","bookWebsiteJournalTitle":"National Heart, Lung, and Blood Institute","date":"5/17/2012","volume":"","pages":"","url":"https://www.nhlbi.nih.gov/health/health-topics/topics/aplastic/treatment","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12711,"authors":"","articleTitle":"Treatments","bookWebsiteJournalTitle":"The Aplastic Anemia and MDS International Foundation","date":"4/19/2016","volume":"","pages":"","url":"http://www.aamds.org/diseases/aplastic-anemia/treatment","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":15549,"phenoTypeName":"Aplastic anemia","frequencyText":"Obligate","percentRanges":"100%"},{"phenoTypeId":9566,"phenoTypeName":"Bone marrow hypocellularity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15515,"phenoTypeName":"Pancytopenia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15532,"phenoTypeName":"Reticulocytopenia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12860,"phenoTypeName":"Ecchymosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9809,"phenoTypeName":"Gingival bleeding","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10671,"phenoTypeName":"Recurrent infections","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9163,"phenoTypeName":"Retinal hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":743,"genericName":"Eltrombopag","tradeName":"Promacta","tradeLink":"https://www.us.promacta.com/","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corp.","indication":"November 2018, eltrombopag (Promacta) was approved in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia. In August 2014, it was approved for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/promacta","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a609011.html"}],"EncodedName":"Aplastic_anemia"}